Literature DB >> 12651626

Deletion, mutation, and loss of expression of KLF6 in human prostate cancer.

Ceshi Chen1, Eija-Riitta Hyytinen, Xiaodong Sun, Heikki J Helin, Pasi A Koivisto, Henry F Frierson, Robert L Vessella, Jin-Tang Dong.   

Abstract

Kruppel-like factors (KLFs) are a group of transcription factors that appear to be involved in different biological processes including carcinogenesis. In a recent study, KLF6 was reported as a tumor suppressor gene in prostate cancer because of its frequent loss of heterozygosity (LOH) and mutation as well as functional suppression of cell proliferation. Loss of chromosomal locus spanning KLF6 is relatively infrequent in other published studies of prostate cancer, however. To clarify the role of KLF6 in prostate cancers, particularly those that are high grade, we examined KLF6 for deletion, mutation, and loss of expression in 96 prostate cancer samples including 21 xenografts/cell lines. Loss of heterozygosity occurred in 4 (19%) of 21 xenografts/cell lines and 8 (28%) of 29 informative tumors. Fourteen of the 96 (15%) samples showed 15 somatic sequence changes in the KLF6 gene, including 7 that changed KLF6 peptide sequences, 4 that did not, and 4 that were located in untranslated regions. Expression levels of KLF6 were significantly lost in 4 of 20 (20%) xenografts/cell lines of prostate cancer, as detected by RT-PCR and Northern blot analysis. These findings indicate that significant genetic alterations of KLF6 occur in a minority of high-grade prostate cancers.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12651626      PMCID: PMC1851229          DOI: 10.1016/S0002-9440(10)63930-2

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  21 in total

Review 1.  A tale of three fingers: the family of mammalian Sp/XKLF transcription factors.

Authors:  S Philipsen; G Suske
Journal:  Nucleic Acids Res       Date:  1999-08-01       Impact factor: 16.971

2.  High frequency of clonal chromosome abnormalities in prostatic neoplasms sampled by prostatectomy or ultrasound-guided needle biopsy.

Authors:  M R Teixeira; H Waehre; R A Lothe; A E Stenwig; N Pandis; K E Giercksky; S Heim
Journal:  Genes Chromosomes Cancer       Date:  2000-06       Impact factor: 5.006

3.  Inactivation of the tumor suppressor PTEN/MMAC1 in advanced human prostate cancer through loss of expression.

Authors:  Y E Whang; X Wu; H Suzuki; R E Reiter; C Tran; R L Vessella; J W Said; W B Isaacs; C L Sawyers
Journal:  Proc Natl Acad Sci U S A       Date:  1998-04-28       Impact factor: 11.205

4.  Localization of multiple melanoma tumor-suppressor genes on chromosome 11 by use of homozygosity mapping-of-deletions analysis.

Authors:  E K Goldberg; J M Glendening; Z Karanjawala; A Sridhar; G J Walker; N K Hayward; A J Rice; D Kurera; Y Tebha; J W Fountain
Journal:  Am J Hum Genet       Date:  2000-07-29       Impact factor: 11.025

5.  Distinct areas of allelic loss on chromosomal regions 10p and 10q in human prostate cancer.

Authors:  T M Trybus; A C Burgess; K J Wojno; T W Glover; J A Macoska
Journal:  Cancer Res       Date:  1996-05-15       Impact factor: 12.701

6.  Three distinct regions of allelic loss at 13q14, 13q21-22, and 13q33 in prostate cancer.

Authors:  E R Hyytinen; H F Frierson; J C Boyd; L W Chung; J T Dong
Journal:  Genes Chromosomes Cancer       Date:  1999-06       Impact factor: 5.006

7.  Tissue, cell type, and breast cancer stage-specific expression of a TGF-beta inducible early transcription factor gene.

Authors:  M Subramaniam; T E Hefferan; K Tau; D Peus; M Pittelkow; S Jalal; B L Riggs; P Roche; T C Spelsberg
Journal:  J Cell Biochem       Date:  1998-02-01       Impact factor: 4.429

8.  Allelic losses at loci on chromosome 10 are associated with metastasis and progression of human prostate cancer.

Authors:  A Komiya; H Suzuki; T Ueda; R Yatani; M Emi; H Ito; J Shimazaki
Journal:  Genes Chromosomes Cancer       Date:  1996-12       Impact factor: 5.006

9.  Allelic loss on chromosome 10 in prostate adenocarcinoma.

Authors:  M Ittmann
Journal:  Cancer Res       Date:  1996-05-01       Impact factor: 12.701

10.  Suppression of the malignant phenotype of human prostate cancer cell line PPC-1 by introduction of normal fragments of human chromosome 10.

Authors:  Y S Murakami; H Albertsen; A R Brothman; R J Leach; R L White
Journal:  Cancer Res       Date:  1996-05-01       Impact factor: 12.701

View more
  44 in total

Review 1.  Krüppel cripples prostate cancer: KLF6 progress and prospects.

Authors:  Goutham Narla; Scott L Friedman; John A Martignetti
Journal:  Am J Pathol       Date:  2003-04       Impact factor: 4.307

2.  Energy restriction-mimetic agents induce apoptosis in prostate cancer cells in part through epigenetic activation of KLF6 tumor suppressor gene expression.

Authors:  Chun-Han Chen; Po-Hsien Huang; Po-Chen Chu; Mei-Chuan Chen; Chih-Chien Chou; Dasheng Wang; Samuel K Kulp; Che-Ming Teng; Qianben Wang; Ching-Shih Chen
Journal:  J Biol Chem       Date:  2011-01-31       Impact factor: 5.157

Review 3.  Tumor suppressor and hepatocellular carcinoma.

Authors:  Juliette Martin; Jean-Francois Dufour
Journal:  World J Gastroenterol       Date:  2008-03-21       Impact factor: 5.742

4.  MicroRNA-181a promotes gastric cancer by negatively regulating tumor suppressor KLF6.

Authors:  Xiangyang Zhang; Yuqiang Nie; Yanlei Du; Jie Cao; Bo Shen; Yuyuang Li
Journal:  Tumour Biol       Date:  2012-05-12

Review 5.  Emerging roles of Kruppel-like factor 6 and Kruppel-like factor 6 splice variant 1 in ovarian cancer progression and treatment.

Authors:  Analisa DiFeo; Goutham Narla; John A Martignetti
Journal:  Mt Sinai J Med       Date:  2009-12

6.  Effects of Kruppel-like factor 6 on osteosarcoma cell biological behavior.

Authors:  Zhu Jianwei; Bai Enzhong; Liu Fan; Liu Jian; An Ning
Journal:  Tumour Biol       Date:  2013-01-16

7.  TGF-beta regulates the expression of transcription factor KLF6 and its splice variants and promotes co-operative transactivation of common target genes through a Smad3-Sp1-KLF6 interaction.

Authors:  Luisa M Botella; Francisco Sanz-Rodriguez; Yusuke Komi; Africa Fernandez-L; Elisa Varela; Eva M Garrido-Martin; Goutham Narla; Scott L Friedman; Soichi Kojima
Journal:  Biochem J       Date:  2009-04-15       Impact factor: 3.857

8.  Decreased expression of KLF6 and its significance in gastric carcinoma.

Authors:  Qing Zhang; Xiao-ping Tan; Yue-sha Yuan; Cheng-ming Hu; Chang-hua He; Wei-zheng Wang; Jun-chuan Li; Qiu Zhao; Nan-zhi Liu
Journal:  Med Oncol       Date:  2009-12-05       Impact factor: 3.064

Review 9.  p21 in cancer: intricate networks and multiple activities.

Authors:  Tarek Abbas; Anindya Dutta
Journal:  Nat Rev Cancer       Date:  2009-06       Impact factor: 60.716

Review 10.  Essential role of KLF5 transcription factor in cell proliferation and differentiation and its implications for human diseases.

Authors:  Jin-Tang Dong; Ceshi Chen
Journal:  Cell Mol Life Sci       Date:  2009-05-16       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.